NCT03235089

Brief Summary

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2017

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 1, 2017

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 3, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 3, 2017

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

October 14, 2020

Completed
Last Updated

October 14, 2020

Status Verified

September 1, 2020

Enrollment Period

9 days

First QC Date

July 27, 2017

Results QC Date

September 1, 2020

Last Update Submit

September 21, 2020

Conditions

Outcome Measures

Primary Outcomes (16)

  • Horizontal Lens Centration Assessed in Primary Gaze

    Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value)

    Baseline

  • Horizontal Lens Centration Assessed in Primary Gaze

    Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value)

    6-hour

  • Vertical Lens Centration Assessed in Primary Gaze

    Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value)

    Baseline

  • Vertical Lens Centration Assessed in Primary Gaze

    Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value)

    6-hours

  • Lens Tightness Assessed by Push-up Test

    Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)

    Baseline

  • Lens Tightness Assessed by Push-up Test

    Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)

    6-hours

  • Primary Gaze Lag Assessed Observing Lens Movement in Graticule

    Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)

    Baseline

  • Primary Gaze Lag Assessed Observing Lens Movement in Graticule

    Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)

    6 hours

  • Horizontal Lens Lag Assessed Observing Lens Movement in Graticule

    Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)

    Baseline

  • Horizontal Lens Lag Assessed Observing Lens Movement in Graticule

    Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)

    6 hours

  • Overall Lens Fit Acceptance

    Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)

    Baseline

  • Overall Lens Fit Acceptance

    Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)

    6 hours

  • Up Gaze Lag Assessed Observing Lens Movement in Graticule

    Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).

    Baseline

  • Up Gaze Lag Assessed Observing Lens Movement in Graticule

    Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).

    6 hours

  • Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink

    Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink

    Baseline

  • Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink

    Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink

    6 hours

Study Arms (2)

Test lens

ACTIVE COMPARATOR

Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).

Device: Test LensDevice: Control Lens

nelfilcon A lens (control)

ACTIVE COMPARATOR

Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).

Device: Test LensDevice: Control Lens

Interventions

Test LensDEVICE

Daily disposable contact lens

Test lensnelfilcon A lens (control)

Focus Dailies All Day Comfort contact lens (nelfilcon A)

Test lensnelfilcon A lens (control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Is at least 18 years of age and has full legal capacity to volunteer
  • Has read, fully understood and signed the information consent letter
  • Currently wears or has previously worn soft contact lenses
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
  • Has clear corneas and no active ocular disease
  • Is willing and able to follow product usage instructions and maintain the visit schedule.

You may not qualify if:

  • Has never worn contact lenses before
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • Has any known active ocular disease and/or infection
  • Has a monovision correction
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses
  • Is aphakic
  • Has undergone corneal refractive surgery
  • Is pregnant or lactating, determined by self-report

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

Bloomington, Indiana, 47405, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Lee Hall, BSc, PhD, MCOptom, FBCLA
Organization
CooperVision, Inc

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Both subject and investigator will be masked to lens type for each eye. A different investigator will select the study lenses for insertion by the subject, from those performing the assessments in order to maintain masking.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a non-dispensing, double-masked, contralateral study comparing test contact lens against a nelfilcon A control lens. Subjects will be randomized to wear the test lens in one eye and the control lens in the other. It is anticipated that this study will involve up to 2 scheduled visits, at Baseline (BL) and 6 hours.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2017

First Posted

August 1, 2017

Study Start

July 25, 2017

Primary Completion

August 3, 2017

Study Completion

August 3, 2017

Last Updated

October 14, 2020

Results First Posted

October 14, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations